Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction (Q47678289)

4 February 2018

title

Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction (English)

1 reference

4 February 2018

spike glycoprotein [SARS-Cov]

0 references

1 reference

0 references

0 references

author name string

Tin-Yun Ho

1

1 reference

4 February 2018

Shih-Lu Wu

2

1 reference

4 February 2018

Jaw-Chyun Chen

3

1 reference

4 February 2018

Yen-Chiao Wei

4

1 reference

4 February 2018

Shin-Ei Cheng

5

1 reference

4 February 2018

Yung-Hsien Chang

6

1 reference

4 February 2018

Hsu-Jan Liu

7

1 reference

4 February 2018

Chien-Yun Hsiang

8

1 reference

4 February 2018

publication date

28 November 2005

1 reference

4 February 2018

published in

Antiviral Research

1 reference

4 February 2018

volume

69

1 reference

4 February 2018

issue

2

1 reference

4 February 2018

page(s)

70-76

1 reference

4 February 2018

Prediction of the Secondary Structure of Proteins from their Amino Acid Sequence

cites work

1 reference

12 December 2020

Structural characterization of the SARS-coronavirus spike S fusion protein core.

1 reference

12 December 2020

Small molecule inhibition of hepatitis C virus E2 binding to CD81

1 reference

12 December 2020

Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.

1 reference

12 December 2020

Design of recombinant protein-based SARS-CoV entry inhibitors targeting the heptad-repeat regions of the spike protein S2 domain

1 reference

12 December 2020

Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide

1 reference

12 December 2020

Aetiology: Koch's postulates fulfilled for SARS virus

1 reference

12 December 2020

Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor

1 reference

12 December 2020

New developments in anti-HIV chemotherapy

1 reference

12 December 2020

The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex

1 reference

12 December 2020

Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.

1 reference

12 December 2020

Virus entry: molecular mechanisms and biomedical applications

1 reference

12 December 2020

The spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells

1 reference

12 December 2020

Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein

1 reference

12 December 2020

Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

1 reference

12 December 2020

The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterization

1 reference

12 December 2020

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

12 December 2020

An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein

1 reference

12 December 2020

The SARS-CoV S glycoprotein: expression and functional characterization

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

A simple method for displaying the hydropathic character of a protein

1 reference

12 December 2020

S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients

1 reference

12 December 2020

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1 reference

12 December 2020

Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents

1 reference

12 December 2020

Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors

1 reference

12 December 2020

Morin inhibits 12-O-tetradecanoylphorbol-13-acetate-induced hepatocellular transformation via activator protein 1 signaling pathway and cell cycle progression

1 reference

12 December 2020

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

1 reference

12 December 2020

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants

1 reference

12 December 2020

Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro

1 reference

12 December 2020

The Genome sequence of the SARS-associated coronavirus

1 reference

12 December 2020

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

12 December 2020

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

12 December 2020

Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor

1 reference

12 December 2020

10.1016/J.ANTIVIRAL.2005.10.005

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018